Key points are not available for this paper at this time.
Follow-up of abnormal results is essential to cervical cancer screening, but data on adherence to follow-up are limited. We describe patterns of follow-up after screening abnormalities and identify predictors of guideline-concordant follow-up.
Cheng et al. (Tue,) studied this question.